Related Experiment Videos
Flurbiprofen-associated acute tubulointerstitial nephritis
J Kaufhold1, M Wilkowski, K McCabe
1Department of Medicine, Wilford Hall USAF Medical Center, Lackland, Tex.
American Journal of Nephrology
|January 1, 1991
Summary
A patient developed acute tubulointerstitial nephritis after taking flurbiprofen, a nonsteroidal anti-inflammatory drug. This condition, confirmed by biopsy, resolved after discontinuing the medication.
Area of Science:
- Nephrology
- Pharmacology
- Drug-induced diseases
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used for pain and inflammation.
- NSAIDs, including propionic acid derivatives like flurbiprofen, can cause renal adverse effects.
- Acute tubulointerstitial nephritis (AIN) is a potential, though uncommon, side effect of NSAID use.
Observation:
- A case study detailing a patient's experience with flurbiprofen.
- The patient presented with symptoms consistent with acute tubulointerstitial nephritis.
- Renal biopsy confirmed the diagnosis of acute tubulointerstitial nephritis.
Findings:
- The patient's acute tubulointerstitial nephritis was biopsy-proven.
- The condition was associated with a second course of flurbiprofen, a propionic acid-class NSAID.
- The clinical presentation and disease course were characteristic of NSAID-induced AIN.
Implications:
- This case highlights the risk of NSAID-induced acute tubulointerstitial nephritis.
- Clinicians should consider AIN in patients presenting with renal dysfunction after NSAID exposure.
- Prompt recognition and discontinuation of the offending NSAID are crucial for managing drug-induced AIN.